微切口白内障超声乳化联合微创玻璃体切割手术治疗并发白内障的玻璃体视网膜疾病  

Microincision phacoemulsification combined with 23-gaug vitrectomy for vitreoretinal diseases and cataract

作　　者：荣华[1] 张美萍[1] 陈建梅[2] 崔红平[1] 

机构地区：[1]同济大学附属东方医院眼科,上海市200120 [2]同济大学附属东方医院手术室,上海市200120

出　　处：《眼科新进展》2013年第11期1062-1065,共4页Recent Advances in Ophthalmology

摘　　要：目的探讨2．2mm微切口白内障超声乳化联合23G微创玻璃体切割手术治疗8月96例（106眼）合并不同程度白内障的玻璃体视网膜疾病患者，均行2．2mm微切口白内障超声乳化联合23G微创玻璃体切割手术的临床资料，术后随访6～12个月，观察术后视力改善程度及术中、术后并发症情况。结果所有病例均顺利完成手术，术后最佳矫正视力较术前提高91眼（占85．85％），视力不变15眼（占14．15％）；术后早期常见的并发症有角膜水肿、前房反应和一过性高眼压。角膜水肿的发生率为9．43％，前房反应的发生率为8．49％，术后一过性高眼压（术后1个月内眼压高于25mmHg，1kPa=7．5mmHg）的发生率为19．81％；术后6个月有12眼（11．32％）发生后囊膜混浊，其中5眼行Nd：YAG激光后囊切开术。结论2．2mm微切口白内障超声乳化联合23G微创玻璃体切割手术治疗并发白内障的玻璃体视网膜疾病是安全有效的。Objective To investigate the clinical efficacy of 2.2 mm microincision phacoemulsification combined with 23-gauge transconjunctival sutureless vitrectomy for vitreoretinal diseases and cataract. Methods This retrospective review consis- ted of 106 eyes of 96 patients with vitreoretinal diseases and clinical significant cataract in our hospital from December 2010 to August 2011. All cases received 2.2 mm microincision cataract surgery combined with 23-gauge vitrectomy. The postoperative follow-up ranged from 6 months to 12 months. Postoperative visual acuity and surgical complications were analyzed. Results All cases were successfully completed surgery. Best corrected visual acuity improved in 91 eyes（85.85% ） ,stabled in 15 eyes（ 14.15% ）. The major postoperative early complications were corneal edema（9.43% ）, fibrinous exudation in the anterior chamber（8.49% ） and transient intraocular pressure rise（ 19.81% ）. Posterior capsule opacifieation were found at postoperative 6 months in 12 eyes （ 11.32% ） ,in which 5 eyes performed Nd： YAG capsulotomy. Conclusion 2.2 mm microincision phacoemulsification combined with 23-gauge transconjunctival sutureless vitrectomy is safe and effective for vitreoretinal diseases and cataract.

关 键 词：玻璃体切割术 微切口超声乳化术 玻璃体视网膜疾病 白内障 

分 类 号：R779.6[医药卫生—眼科]